Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia

NCT05827549

Conditions
Acute Lymphoid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Chonnam National University Hwasun Hospital Hwasun, South Korea
  • Seoul National University Hospital Seoul, South Korea
  • Severance Hospital Seoul, South Korea
  • Asan Medical Center Seoul, South Korea
View Trial Details
Recruiting

Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies

NCT05541341

Conditions
Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Follicular Lymphoma, +16 more
Locations
  • Novartis Investigative Site Minas Gerais, Belo Horizonte, Brazil
  • Novartis Investigative Site Salvador, Estado de Bahia, Brazil
  • Novartis Investigative Site Curitiba, Paraná, Brazil
  • Novartis Investigative Site São Paulo, Brazil
View Trial Details
Recruiting

Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation

NCT06793410

Conditions
Acute Myeloid Leukaemia, Bone Marrow Diseases, Communicable Diseases, +32 more
Locations
  • Skåne's University Hospital Lund, Region Skåne, Sweden
  • Karolinska University Hospital Stockholm, Region Stockholm, Sweden
  • Uppsala University Hospital Uppsala, Region Uppsala, Sweden
  • Linköping University Hospital Linköping, Region Östergötaland, Sweden
View Trial Details
Recruiting

MRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymphoma

NCT06414148

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • Westmead Hospital Westmead, New South Wales, Australia
  • Royal Brisbane and Women's Hospital Herston, Queensland, Australia
  • Alfred Hospital Melbourne, Victoria, Australia
View Trial Details
Recruiting

A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLL

NCT06547528

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +18 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • Nagoya University Hospital Nagoya, Aichi-ken, Japan
  • Akita University Hospital Akita, Japan
  • National Cancer Center Hospital East Kashiwa-shi, Chiba, Japan
View all 14 locations
View Trial Details
Recruiting

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

NCT06119685

Conditions
Blood Cancer, Blood Protein Disorders, Cardiovascular Diseases, +23 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Florida Cancer Specialists and Research Institute - Lake Mary Cancer Center Lake Mary, Florida, United States
  • Emory University Hospital Atlanta, Georgia, United States
  • University of Minnesota Minneapolis, Minnesota, United States
View Trial Details

Related conditions